Self-Interest versus Group-Interest in Antiviral Control
Michiel van Boven, Don Klinkenberg, Ido Pen et al. · 2008
Read Self-Interest versus Group-Interest in Antiviral Control by Michiel van Boven, Don Klinkenberg, Ido Pen et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001558.txt.
Description
Michiel van Boven and co-authors published a 2008 PLOS ONE study on when people will take flu drugs. Drugs that curb viruses hold promise for new ills such as bird flu and SARS. But the drugs are not free of harm, so people weigh gain against risk. The team modeled when self interest and group gain pull in unlike ways.
In their model, what pays for one person can fail the group as a whole. That gap can stall a drug drive that needs wide uptake to work. Plans must thus align the two, with clear rules and fair access. The work frames a social snag that pure drug science cannot solve.
Catalog record
| CREATOR | Michiel van Boven, Don Klinkenberg, Ido Pen et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001558